Louisiana State University: Participants Taking Experimental Monoclonal Antibody Lost 21% of Total Body Fat
February 03, 2021
February 03, 2021
BATON ROUGE, Louisiana, Feb. 3 (TNSJou) -- The Louisiana State University's Pennington Biomedical Research Center issued the following news release on Feb. 2, 2021:
People with type 2 diabetes and obesity lost 21 percent of their body fat after taking an experimental monoclonal antibody called Bimagrumab for 48 weeks, while participants who took a placebo lost 0.5 percent of their body fat, a new study shows.
The results of the study were published today in JAMA Ne . . .
People with type 2 diabetes and obesity lost 21 percent of their body fat after taking an experimental monoclonal antibody called Bimagrumab for 48 weeks, while participants who took a placebo lost 0.5 percent of their body fat, a new study shows.
The results of the study were published today in JAMA Ne . . .